Skip to main content
Scott Peslak, MD, Hematology, Philadelphia, PA

ScottAlanPeslakMDPhD

Hematology Philadelphia, PA

Medical Resident at the Hospital of the University of Pennsylvania

Dr. Peslak is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Peslak's full profile

Already have an account?

  • Office

    3400 Spruce Street
    Hospital Of The University Of Pennsylvania, 100 Centrex
    Philadelphia, PA 19104
    Phone+1 267-303-6321
    Fax+1 215-662-7919

Education & Training

  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemResidency, Internal Medicine, 2014 - 2017
  • University of Rochester School of Medicine and Dentistry
    University of Rochester School of Medicine and DentistryClass of 2014

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 2014 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Hematology

Publications & Presentations

PubMed

Abstracts/Posters

  • Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes
    Scott A. Peslak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Heme-Regulated Inhibitor (HRI) Activates Transcription Factor ATF4 to Promote BCL11A Transcription and Fetal Hemoglobin Silencing
    Scott A. Peslak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
  • Understanding Heterogeneity of Fetal Hemoglobin Induction through Comparative Analysis of Stage-Matched F- and a-Cells
    Scott A. Peslak, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019

Lectures

  • Heme-Regulated Inhibitor (HRI) Depletion Cooperates with Pharmacologic Inducers to Strongly Elevate Fetal Hemoglobin and Reduce Sickle Cell Formation 
    61st Annual American Society of Hematology Meeting - Orlando, FL - 12/7/2019